Here, we document IGF-1 effects on coronary atherosclerosis in FH pigs, using recombinant human IGF-1 at a dose that is FDA approved for long-term treatment of growth failure in children with severe primary IGF-1 deficiency. Here, IGF1 is linked to coronary atherosclerosis.